Search

CNE objectives/questions After reading Contraceptive Technology Update, the participant will be able to: identify clinical, legal, or scientific issues related to development and provisions of contraceptive technology or other reproductive [...]

CNE/CME objectives/questions After reading Contraceptive Technology Update, the participant will be able to: identify clinical, legal, or scientific issues related to development and provisions of contraceptive technology or other reproductive [...]

Pharmacology Update Ulipristal Acetate Tablets (EllaO) By William T. Elliott, MD, FACP, and James Chan, PharmD, PhD. Dr. Elliott is Chair, Formulary Committee, Northern California Kaiser Permanente; and Assistant Professor [...]

CNE/CME objectives/questions After reading Contraceptive Technology Update, the participant will be able to: identify clinical, legal, or scientific issues related to development and provisions of contraceptive technology or other reproductive [...]

Contraceptive Care Made Easy Abstract & Commentary By Alison Edelman, MD, MPH, Associate Professor, Assistant Director of the Family Planning Fellowship Department of Obstetrics & Gynecology, Oregon Health & Science [...]

Advocates up awareness for female condom use Heads up for reproductive health and family planning clinics in California and Nevada: The Female Health Co.'s free FC2 Female Condom -- Experience [...]

CNE objectives/questions After reading Contraceptive Technology Update, the participant will be able to: identify clinical, legal, or scientific issues related to development and provisions of contraceptive technology or other reproductive [...]

CNE objectives/questions After reading Contraceptive Technology Update, the participant will be able to: identify clinical, legal, or scientific issues related to development and provisions of contraceptive technology or other reproductive [...]

CNE/CME objectives/questions After reading Contraceptive Technology Update, the participant will be able to: identify clinical, legal, or scientific issues related to development and provisions of contraceptive technology or other reproductive [...]

CNE/CME objectives/questions After reading Contraceptive Technology Update, the participant will be able to: identify clinical, legal, or scientific issues related to development and provisions of contraceptive technology or other reproductive [...]

Condom wrap-up -- New options for women & men Good news for patients at your clinic: The second-generation FC2 Female Condom is available for purchase in the United States, which [...]

Options for treatment of heavy bleeding in focus Clinicians now have an approved indication in hand for use of the levonorgestrel intrauterine system Mirena (LNG IUS, Mirena, Bayer HealthCare Pharmaceuticals; [...]

CNE/CME objectives/questions After reading Contraceptive Technology Update, the participant will be able to: identify clinical, legal, or scientific issues related to development and provisions of contraceptive technology or other reproductive [...]

Risk of VTE with Oral Contraceptives Abstract & Commentary By Jeffrey T. Jensen, MD, MPH, Editor, Leon Speroff Professor of Obstetrics and Gynecology, Vice Chair for Research, Oregon Health and [...]

Review data on Pill use and thrombosis risk Despite the findings of two new studies,.sup.1,2 providers should focus on the fact that two earlier, large studies have compared safety data [...]

New data emerge on emergency contraception Family planning clinicians have new research information to add to their emergency contraception (EC) knowledge bank as they incorporate use of two new branded [...]

Coitus interruptus: Is it rare among teens? With the wide array of birth control options available today, are adolescents still relying on coitus interruptus? Results of a 2009 study indicate [...]

More women delay births -- What are their options? A healthy, nonsmoking woman, age 36, waits in your examination room. While she has been married for seven years, she and [...]

New emergency contraception options are here, but how are you to use them? FDA approves Plan B One-Step and Next Choice Getting ready to advise your next patient about the [...]

Obesity and Oral Contraceptive Efficacy Abstract & Commentary By Alison Edelman, MD, MPH, Assistant Professor, Assistant Director of the Family Planning Fellowship, Department of Obstetrics & Gynecology, Oregon Health & [...]

Long-acting Contraception for Pain Control in Patients with Endometriosis Abstract & Commentary By Alison Edelman, MD, MPH, Assistant Professor, Assistant Director of the Family Planning Fellowship, Department of Obstetrics & [...]

'The Pill' Saves Lives! Abstract & Commentary By Alison Edelman, MD, MPH, Assistant Professor, Assistant Director of the Family Planning Fellowship Department of Obstetrics & Gynecology, Oregon Health & Science [...]

Blood clots and 'The Patch' Abstract & Commentary By Alison Edelman, MD, MPH, Assistant Professor, Assistant Director of the Family Planning Fellowship Department of Obstetrics & Gynecology, Oregon Health & [...]

OCs and Endometriosis Abstract & Commentary By Leon Speroff, MD, Editor, Professor of Obstetrics and Gynecology, Oregon Health and Science University, Portland, is Editor for OB/GYN Clinical Alert. Synopsis: A [...]

Progress reported on male contraceptives While women have several options when it comes to birth control, men are limited to condoms and vasectomies. Researchers around the globe are focusing efforts [...]

Post-approval requirements increasing? Hologic gets panel approval for Adiana contraceptive device By MARK McCARTY, Medical Device Daily Washington Editor GAITHERSBURG, Maryland u Several recent FDA panel hearings for medical devices [...]

Oral Contraceptives and Breast Cancer in Young Women Abstract & Commentary By Leon Speroff, MD, Editor, Professor of Obstetrics and Gynecology Oregon Health and Science University, Portland, is Editor for [...]

Snapshot: Shot remains as long-acting option The next patient in your examination room is an 18-year-old female who is seeking effective contraception. She has tried oral contraceptives (OCs), but she [...]

New data released underscores safety of dedicated continuous-use pill Prepare to counsel women on continuous-use oral contraceptive New research released on Lybrel, the first dedicated continuous use oral contraceptive (OC) [...]

CE/CME objectives/questions After reading Contraceptive Technology Update, the participant will be able to: *identify clinical, legal, or scientific issues related to development and provisions of contraceptive technology or other reproductive [...]

To The Editor: I am writing to provide important details from the Today contraceptive sponge worldwide Phase III clinical trial that were not presented in your recent article in Contraceptive [...]

CE/CME objectives/questions After reading Contraceptive Technology Update, the participant will be able to: *Identify clinical, legal, or scientific issues related to development and provisions of contraceptive technology or other reproductive [...]

CE/CME objectives/questions After reading Contraceptive Technology Update, the participant will be able to: *identify clinical, legal, or scientific issues related to development and provisions of contraceptive technology or other reproductive [...]

Banish the myths about fertility, contraception Review the following scenario: a patient has used oral contraceptives for 15 years, starting her first pill pack at age 28. Now at age [...]

FDA okay of OTC Plan B sale may clear way for commish By HOLLAND JOHNSON Medical Device Daily Associate Managing Editor After countless delays that many say were based on [...]

FDA approves Implanon as single implant for birth control By KAREN YOUNG Medical Device Daily Staff Writer Women now have a new choice in contraceptives: a single-rod implant called Implanon [...]

CTU remembers Felicia Stewart, MD Felicia Hance Stewart, MD, co-author of Contraceptive Technology and member of the Contraceptive Technology Update Editorial Board, died April 12 of lung cancer at her [...]

Spray-on contraceptive moves to next step Scientists are preparing to take the next step in the search for a spray-on contraceptive, with a Phase II trial scheduled for the second [...]

CE/CME objectives/questions After reading Contraceptive Technology Update, the participant will be able to: Identify clinical, legal, or scientific issues related to development and provision of contraceptive technology or other reproductive [...]

Shortening the pill-free interval: New contraceptives take next step Shorter interval may decrease incidence of hormone-withdrawal symptoms Do you remember Enovid, the first oral contraceptive (OC)? Introduced in 1960 by [...]

aeQuick StartAE approach eyed for DMPA and patch Current package labeling for the contraceptive injection depot medroxyprogesterone acetate (DMPA) (Depo-Provera, Pfizer, New York City) calls for the method to be [...]

CE/CME questions After reading Contraceptive Technology Update, the participant will be able to: Identify clinical, legal, or scientific issues related to development and provisions of contraceptive technology or other reproductive [...]

Contraception, weight gain: Weigh evidence and myths Counter perceptions with evidence-based counseling When it comes to weight, patients may discontinue use of hormonal contraception if extra pounds are encountered. Can [...]

Do OCs impact libido? More research needed A patient tells you she heard a news story that said that oral contraceptives (OCs) have lasting effect on hormone levels, dulling a [...]

EVRA and Venous Thrombosis Abstract & Commentary By Leon Speroff, MD, Editor, Professor of Obstetrics and Gynecology, Oregon Health and Science University, Portland, is Editor for OB/GYN Clinical Alert. Synopsis: [...]

Use the phone and web to expand EC access While women wait for a decision from the Food and Drug Administration (FDA) on the status of moving emergency contraception over [...]

Systemic Lupus Erythematosus and Contraception Abstract & Commentary By Leon Speroff, MD, Editor, Professor of Obstetrics and Gynecology, Oregon Health and Science University, Portland, is Editor for OB/GYN Clinical Alert. [...]

FDA revises Evra safety labeling due to increased estrogen levels Patch may expose users to about 60% more estrogen than 35 mcg pill Get ready to discuss questions about the [...]

FDA okays new labeling on estrogen in birth control patch A Medical Device Daily Staff Report The FDA has approved updated labeling for the Ortho Evra contraceptive patch to warn [...]